SCHEMBL16368787

SCHEMBL16368787

CC(C)(C)N(CN)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17085315 0.83
SCHEMBL5667895 0.72 CYP2D6 (0.32)
SCHEMBL1103778 0.67
SCHEMBL17537485 0.67 MEN1 (0.30)
SCHEMBL9640729 0.67 CHRM2 (0.38)
SCHEMBL17211409 0.67
SCHEMBL15932257 0.65
SCHEMBL22989724 0.65
SCHEMBL627752 0.64
SCHEMBL21310486 0.62 CYP2D6 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180042996-A1 Hydrogel-Linked IL-1ra Prodrug ASCENDIS PHARMA OSTEOARTHRITIS DIVISION A/S (DK) 2018-02-15 US disclosed
US-9855340-B2 Hydrogel prodrugs ASCENDIS PHARMA A/S (DK) 2018-01-02 US disclosed
US-20170224829-A1 Prodrugs Comprising an Aminoalkyl Glycine Linker ASCENDIS PHARMA A/S (DK) 2017-08-10 US disclosed
US-20170112939-A1 PREVENTION AND TREATMENT OF OCULAR CONDITIONS Ascendis Pharma Ophthamology Division A/S (DK) 2017-04-27 US disclosed
US-20160296600-A1 Relaxin Prodrugs ASCENDIS PHARMA RELAXIN DIVISION A/S (DK) 2016-10-13 US disclosed
US-20160089446-A1 Modified Hydrogels ASCENDIS PHARMA A/S (DK) 2016-03-31 US disclosed
US-20160082123-A1 Hydrogel-Linked Prodrugs Releasing Tagged Drugs ASCENDIS PHARMA A/S (DK) 2016-03-24 US disclosed
US-20150297740-A1 VEGF Neutralizing Prodrugs for the Treatment of Ocular Conditions ASCENDIS PHARMA INC. 2015-10-22 US disclosed
US-20150258205-A1 Hydrogel Prodrugs ASCENDIS PHARMA GMBH (DE) 2015-09-17 US disclosed
US-20150010634-A1 PREVENTION AND TREATMENT OF OCULAR CONDITIONS Ascendis Pharma Ophthamology Division A/S (DK) 2015-01-08 US disclosed